The landscape of medical artificial intelligence (AI) is experiencing unprecedented momentum. Since January, 2023, the number ...

On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...

People with dementia face a long road to diagnosis, according to a comprehensive review published in the International ...

Learn how to systematically evaluate six core ETF strategies for clients, from passive index funds to thematic investing, with practical frameworks and scripts.